(Q51163667)

31 March 2018

title

Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03097.X

12 December 2022

1 reference

1 reference

S. Andersch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1862730

12 December 2022

N. K. Rosenberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1862730

12 December 2022

H. Kullingsjö

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1862730

12 December 2022

J. O. Ottosson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1862730

12 December 2022

P. Bech

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1862730

12 December 2022

J. Bruun-Hansen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1862730

12 December 2022

L. Hanson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1862730

12 December 2022

K. Lorentzen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1862730

12 December 2022

M. Mellergård

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1862730

12 December 2022

S. Rasmussen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1862730

12 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1862730

12 December 2022

publication date

1 January 1991

1 reference

31 March 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0447.1991.tb03097.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03097.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0447.1991.tb03097.x/fullpdf

12 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03097.X

Acta psychiatrica Scandinavica. Supplementum

12 December 2022

published in

1 reference

31 March 2018

volume

365

1 reference

31 March 2018

page(s)

18-27

1 reference

31 March 2018

Psychiatric reaction patterns to imipramine

cites work

3

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03097.X

Research diagnostic criteria: rationale and reliability

12 December 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03097.X

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites

12 December 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03097.X

Antidepressant drugs in anxiety disorders.

12 December 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03097.X

Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study

12 December 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03097.X

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

12 December 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03097.X

British Journal of Psychiatry

12 December 2022

12

author name string

Second phase investigators, cross-national collaborative panic study

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03097.X

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

12 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03097.X

The assessment of anxiety states by rating

12 December 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03097.X

Brief standard self-rating for phobic patients

12 December 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03097.X

A rating scale for depression

12 December 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03097.X

Treatment of phobic states with antidepressants. A retrospective study of 246 patients

12 December 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03097.X

Applied relaxation vs progressive relaxation in the treatment of panic disorder.

12 December 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03097.X

12 December 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1862730

12 December 2022

1 reference

31 March 2018